The ITZA Program: Indigenous HIV/AIDS Research Training 3 (IHART3) Program

美洲土著人民在艾滋病毒/艾滋病方面的健康状况长期存在严重差距。 尽管存在着明显的差异，但缺乏基于文化的研究来解决他们的生物医学问题。 和社会行为健康问题。一个由训练有素的土著学者组成的强大网络，致力于 与文化相关的艾滋病毒预防研究将有助于改善与艾滋病毒有关的健康差距 在原住民中。此竞争性更新申请，响应PAR-17-485：NIMH研究 艾滋病毒/艾滋病研究人员教育指导方案（R25），提出了第三次土著 艾滋病毒/艾滋病研究培训方案。IHART 3-Itza将开发一个以文化为基础的土著干部 有能力担任校外资助的艾滋病毒/艾滋病相关预防和差异研究的PI的学者 与土著居民。IHART 3-Itza计划是基于IHART前10年的成功 （IHART和IHART 2-Lauhoe），这是美国唯一一个针对本土的艾滋病毒/艾滋病研究教育导师计划。 我们IHART 3-Itza扩展了美洲印第安人/阿拉斯加土著人的原始IHART计划的范围， 土著夏威夷人/太平洋岛民、代表性不足的种族/族裔群体和以印第安语工作的非土著人 国家也包括历史上服务不足的土著拉丁裔人口（ILP）。ILP包括人 原产于墨西哥、中美洲和南美洲的土著社区或其后裔。而 IHART 2主要集中在新的博士后学者，IHART 3-Itza将针对更有经验的早期- 阶段研究者（博士后5-10年）有兴趣发展艾滋病毒预防方面的新专业知识 research.最后，该计划将针对居住在美国或在美国工作的艾滋病毒热点学者进行招聘 东南部和西部地区。IHART 3-Itza将继续采用成功的360度合作， 灵活的导师制方法，让项目研究员和导师共同确定艾滋病毒培训、职业 文化的需要和发展的需要。为了实现IHART 3-Itza的总体目标，我们将选择 15名研究员（5年内每年3名），他们将接受为期24个月的结构化全年密集辅导 该计划包括：（a）每年2天的夏季研究所，5天的写作务虚会，和3天的 科学圆桌会议和赠款撰写讲习班;（B）其他培训机会（网络研讨会;每季度4次 研讨会;现场辅导员跟踪机会;以及支持参加艾滋病毒/艾滋病培训机构 （c）为编写赠款申请提供统计、编辑和技术援助 （d）种子资金（22 000美元用于试点研究）;（e）网络 发展（通过导师网络和网站）。在为期24个月的项目结束时，研究员将拥有 撰写了一份试点拨款申请，获得了人类受试者的批准，设计并实施了一项资助的试点项目， 研究，发表了与艾滋病毒/艾滋病有关的文章，提交并提交了与艾滋病毒有关的会议摘要， 国家会议，并开始开发一个与艾滋病毒有关的NIH赠款申请。

The Indigenous people of the Americas experience persistent and dire health disparities related to HIV/AIDS. Despite the glaring disparities, there is a paucity of culturally grounded research addressing their biomedical and socio-behavioral health concerns. A strong network of highly trained Indigenous scholars dedicated to culturally relevant HIV prevention research would contribute to ameliorating HIV-related health disparities among Indigenous people. This competitive renewal application, in response to PAR-17-485: NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25), proposes a third iteration of the Indigenous HIV/AIDS Research Training Program (IHART). IHART3-Itza will develop a cadre of culturally grounded Native scholars capable of serving as PIs on extramurally funded HIV/AIDS-related prevention and disparities studies with Indigenous populations. The IHART3-Itza program is based on the success of the first 10 years of IHART (IHART and IHART2-Lauhoe), the only Native-specific HIV/AIDS research education mentorship program in the US. IHART3-Itza extends the reach of the original IHART programs from American Indians/Alaska Natives, Native Hawaian/Pacific Islanders, underrepresented racial/ethnic groups, and non-Natives working in Indian Country to include as well the historically underserved Indigenous Latinx Populations (ILP). ILP include people originally or descended from Indigenous communities in Mexico and Central and South America. Whereas IHART2 focused primarily on newly postdoctoral scholars, IHART3-Itza will target more experienced early- stage investigators (5-10 years post-Ph.D.) interested in developing novel expertise in HIV prevention research. Finally, the program will target recruitment of scholars residing in or working in the US HIV hot spot regions of the Southeast and West. IHART3-Itza will continue to employ a successful 360 degree co- mentorship approach with flexibility for program Fellows and Mentors to co-identify HIV training, career development, and cultural needs of the Fellow. To achieve the overall objectives of IHART3-Itza, we will select 15 Fellows (3 per year over 5 years) who will undergo a structured 24-month intensive year-round mentorship program that includes: (a) an annual 2-day Summer Research Institute, 5-day writing retreat, and 3-day Scientific Roundtable and grant writing workshop; (b) other training opportunities (webinars; 4 quarterly seminars; on-site mentor shadowing opportunities; and support for participation in HIV/AIDS training institutes and scientific conferences); (c) statistical, editorial, and technical assistance for developing grant applications and writing manuscripts for publication); (d) seed funding ($22,000 for pilot studies); and (e) network development (via mentor networks and website). By the end of the 24-month program, Fellows will have written a pilot grant application, obtained human subjects approval, designed and implemented a funded pilot study, published HIV/AIDS-related articles, submitted and presented HIV-related conference abstracts to national conferences, and begun to develop an HIV-related NIH grant application.